01-26-2012 07:50 AM CET - Health & Medicine

The total needle-free delivery market is expected to grow rapidly as more opportunities arise.

Press release from: visiongain
pharmaceutical, contract, drugs, Pharma Market
pharmaceutical, contract, drugs, Pharma Market
A new report by visiongain, a London-based business information provider predicts the global needle-free delivery devices market to be worth almost 5.9 billion dollars by 2022.

The market generated sales of 950.0 million dollars in 2010 according to Needle-Free Delivery: Technology and Market, 2012-2022, published in January 2012.

Needle-free injection technology is a mix of old and new technologies. Jet injectors are a well established segment of the market and will see increased growth over the forecast period. The second segment of the market is the competing technologies market. This segment includes innovative technologies such as microneedle patches.

James Sheppard, healthcare industry analyst says ‘The needle-free delivery market has seen slow growth in recent years and is only now beginning to expand. Growth will be driven by new technologies such as microneedle patches and novel jet injectors. Over the course of the next decade there will be greater demand for needle-free delivery devices as the technology becomes more attractive to big pharmaceutical companies.’

Visiongain’s research suggests that the needle-free delivery market will benefit from reducing prices, increasing efficiency in manufacturing processes and growth of emerging economies. Increasing healthcare awareness in emerging economies will mean more vaccine programs, which will help to drive the market. Mature markets such as the US and Japan will also experience double digit growth.

Needle-free delivery devices will have significant opportunities for growth during the forecast period. Visiongain’s analysis of jet injectors and the competing technologies pipelines showed a great deal of promise in the future. Leading experts in the field, interviewed by visiongain, have stated that there is significant opportunity for growth over the coming years. The products currently in development will offer significant opportunities, aided by advances in nanotechnology.

To view sample pages please click on:
Please contact Sara Peerun for an exec summary:
Email: sara.peerun@visiongainglobal.com
Tel: +44 020 7336 6100

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Telecoms, Energy, Pharmaceutical, Defence, Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

Visiongain Ltd
230 City Road
United Kingdom

This release was published on openPR.
News-ID: 208355 • Views: 1062
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.

You can edit or delete your press release here: